Management of Gout and Hyperuricemia in CKD.
Vargas-Santos AB, Neogi T.
Am J Kidney Dis. 2017 Sep;70(3):422-439. doi: 10.1053/j.ajkd.2017.01.055. Epub 2017 Apr 26.
Uric acid and the kidney.
Fathallah-Shaykh SA, Cramer MT.
Pediatr Nephrol. 2014 Jun;29(6):999-1008. doi: 10.1007/s00467-013-2549-x. Epub 2013 Jul 4.
Seizure-induced acute urate nephropathy: case report and review.
Makki N, Hajj G, Schmidt GA.
Chest. 2013 Aug;144(2):666-669. doi: 10.1378/chest.12-2129.
Coptisine protects against hyperuricemic nephropathy through alleviating inflammation, oxidative stress and mitochondrial apoptosis via PI3K/Akt signaling pathway.
Liu Y, Gong S, Li K, Wu G, Zheng X, Zheng J, Lu X, Zhang L, Li J, Su Z, Liu Y, Xie J, Chen J, Li Y.
Biomed Pharmacother. 2022 Dec;156:113941. doi: 10.1016/j.biopha.2022.113941. Epub 2022 Nov 2.
Insights into renal damage in hyperuricemia: Focus on renal protection (Review).
Yang H, Ying J, Zu T, Meng XM, Jin J.
Mol Med Rep. 2025 Mar;31(3):59. doi: 10.3892/mmr.2024.13424. Epub 2024 Dec 24.
AMP-activated protein kinase alpha2 contributes to acute and chronic hyperuricemic nephropathy via renal urate deposition in a mouse model.
Yang C, Su HY, An N, Wu HL, Guo XY, Li ZH, Chen XC, Zhu SP, Wu D, Li HY, Pan QJ, Liang D, Liu HF.
Eur J Med Res. 2022 Sep 10;27(1):176. doi: 10.1186/s40001-022-00800-1.
Acute uric acid nephropathy.
Robinson RR, Yarger WE.
Arch Intern Med. 1977 Jul;137(7):839-40.
Acute uric acid nephropathy.
Conger JD.
Med Clin North Am. 1990 Jul;74(4):859-71. doi: 10.1016/s0025-7125(16)30522-3.
Hyperuricemia and gout.
German DC, Holmes EW.
Med Clin North Am. 1986 Mar;70(2):419-36. doi: 10.1016/s0025-7125(16)30961-0.
Lacticaseibacillus rhamnosus Fmb14 prevents purine induced hyperuricemia and alleviate renal fibrosis through gut-kidney axis.
Zhao H, Chen X, Zhang L, Meng F, Zhou L, Pang X, Lu Z, Lu Y.
Pharmacol Res. 2022 Aug;182:106350. doi: 10.1016/j.phrs.2022.106350. Epub 2022 Jul 14.
